Zusammenfassung
Die Behandlung von Kindern und Jugendlichen mit Meningomyelozele hat in den letzten 30 Jahren einen deutlichen Wandel erfahren. Die Etablierung der Pharmakotherapie, des sauberen Einmalkatheterismus (clean intermittent catheterization, CIC) und der Infektionsprophylaxe hat die Prognose der Patienten verbessert und zu neuen therapeutischen Strategien geführt. Die interdisziplinäre Zusammenarbeit von Neonatologen, Neurochirurgen Neuropädiatern, Kinderurologen, pädiatrischen Nephrologen, Kinderorthopäden und Kinderchirurgen führt zu einer Optimierung der individuellen Therapie.
In der vorliegenden Konsensusempfehlung werden Definitionen und Klassifikationen, Untersuchungsmethoden und deren idealer Zeitpunkt dargestellt und im Einzelnen erläutert. Hierzu gehören die konservativen und operativen Therapieoptionen bei neurogener Blasenentleerungsstörung, die orthopädischen Probleme, die erhöhte Inzidenz der Latexallergie, Therapieoptionen der Darmentleerung, die Auswirkungen der neurologischen Grunderkrankung auf Sexualität und Fertilität, Diagnostik und Therapie von Harnweginfektionen sowie die Besonderheiten Patientencompliance im Verlauf.
Abstract
Since the 1980s the management of children and adolescents with meningomyelocele has undergone major changes. The introduction of pharmacotherapy with antimuscarinic agents, clean intermittent catheterization (CIC) and antibacterial prophylaxis has revolutionized the management of children with neurogenic bladder. The co-operation between neonatologists, neurosurgeons, paediatric neurologists, paediatricians, paediatric urologists, paediatric nephrologists, paediatric orthopaedists and paediatric surgeons is necessary to achieve an optimized therapy in each individual patient.
In this interdisciplinary consensus paper we provide definitions and classifications as well as a timetable for the appropriate investigations. The conservative and surgical options are explained in detail. A short review is given concerning orthopaedic management, incidence of latex allergy, options for bowel management, diagnosis and treatment of urinary tract infections, problems with sexuality and fertility as well as the long-term compliance of these patients and their relatives.
Literatur
McGuire EJ, Woodside JR, Borden TA, Weiss RM (1981) Prognostic value urodynamic testing in myelodysplastic patients. J Urol 126: 205–209
Bauer SB, Hallett M, Khoshbin S et al. (1984) Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252: 650–652
Galloway NT, Mekras JA, Helms M, Webster GD (1991) An objective score to predict upper tract deterioration in myelodysplasia. J Urol 145: 535–537
Lais A, Kasabian NG, Dyro FM et al. (1993) The neurosurgical implications of continuous neurourological surveillance of children with myelodysplasia. J Urol 150: 1879–1883
Bauer S (2000) Clean intermittent catheterization of infants with myelodysplasia – the argument for early asssessment and treatment of infants with spina bifida. Dialog Ped Urol 23: 2–3
Reiner I, Jones M, Donnell S, Rickwood AM (1992) Incidence of normal micturition in myelomeningocele patients. Arch Dis Child 67: 640–641
Sillen U, Hansson E, Hermansson G et al. (1996) Development of the urodynamic pattern in infants with myelomeningocele. Br J Urol 78: 596–601
Dator DP, Hatchett L, Dyro FM et al. (1992) Urodynamic dysfunction in walking myelodysplastic children. J Urol 148: 362–365
Tarcan T, Bauer S, Olmedo E et al. (2001) Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? J Urol 165: 564–567
Ghoniem GM, Roach MB, Lewis VH, Harmon EP (1990) The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients. J Urol 144: 1440–1442
Beetz R, Bokenkamp A, Brandis M et al. (2001) Diagnosis of congenital dilatation of the urinary tract. Consensus Group of the Pediatric Nephrology Working Society in cooperation with the Pediatric Urology Working Group of the German Society of Urology and with the Pediatric Urology Working Society in the Germany Society of Pediatric Surgery. Urologe A 40: 495–509
Dinkel E, Ertel M, Dittrich M et al. (1985) Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 15: 38–43
Lebowitz RL, Olbing H, Parkkulainen KV et al. (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 15: 105–109
Höfner K (2004) Messung des Leak Point Pressure. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 105–110
Madersbacher H, Stöhrer M, Schönberger B (2004) Urodynamik bei neurogener Blasenfunktionsstörung. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 217–236
Decter RM, Harpster L (1992) Pitfalls in determination of leak point pressure. J Urol 148: 588–591
Thon WF, Denil J, Stief CG, Jonas U (1994) Urologische Langzeitbetreuung von Patienten mit Meningomyelozele. Akt Urol 25: 55–76
Schultz-Lampel D, Schönberger B (2004) Urodynamik bei Blasenfunktionsstörungen des Kindes. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 189–206
Landau EH, Churchill BM, Jayanthi VR et al. (1994) The sensitivity of pressure specific bladder volume versus total bladder capacity as a measure of bladder storage dysfunction. J Urol 152: 1578–1581
Norgaard JP, Gool JD van, Hjalmas K et al. (1998) Standardization and definitions in lower urinary tract dysfunction in children. International Children’s Continence Society. Br J Urol 81(Suppl 3): 1–16
Neveus T, Gontard A von, Hoebeke P et al. (2006) The standardization of terminology of lower urinary tract function in children and adolescents: Report from the Standardisation Committee of the International Children’s Continence Society. J Urol 176: 314–324
Yeung CK (1998) Continuous real-time ambulatory urodynamic monitoring in infants and young children using infrared telemetry. Br J Urol 81(Suppl 3): 76–80
Gordon I, Piepsz A, Colarinha P et al. (2000) Empfehlungen zur Durchführung der Nierenfunktionsszintigraphie mit und ohne Furosemidbelastung. Leitlinie übernommen vom Pediatric Committee der European Association of Nuclear Medicine (EANM) (2000). Nuklearmediziner 4: 297–309
Schwartz G, Brion L, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: 571–590
Adolescents NHBPEPWGoHCiCa (1996) Update on the 1987 Task Force Report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98: 649–658
Goessl C, Knispel HH, Fiedler U et al. (1998) Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology 51: 94–98
Haferkamp A, Staehler G, Gerner HJ, Dorsam J (2000) Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 38: 250–254
Ferrara P, D’Aleo CM, Tarquini E et al. (2001) Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int 87: 674–678
Connor JP, Betrus G, Fleming P et al. (1994) Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 151: 1045–1047
Kaplinsky R, Greenfield S, Wan J, Fera M (1996) Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder. J Urol 156: 753–756
Oka T, Nakano K, Kirimoto T, Matsuura N (2001) Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats. Jpn J Pharmacol 87: 27–33
Todorova A, Vonderheid-Guth B, Dimpfel W (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41: 636–644
Perrigot M, Delauche-Cavallier MC, Amarenco G et al. (1996) Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunction. DORALI Study Group. Neurourol Urodyn 15: 119–131
Austin PF, Homsy YL, Masel JL et al. (1999) alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol 162: 1064–1067
Donohoe JM, Combs AJ, Glassberg KI (2005) Primary bladder neck dysfunction in children and adolescents II: Results of treatment with alpha-adrenergic antagonists. J Urol 173: 212–216
Park JM, McGuire EJ, Koo HP et al. (2001) External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience. J Urol 165: 2383–2388
Bloom DA, Knechtel JM, McGuire EJ (1990) Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures. J Urol 144: 430–444
Shochat SJ, Perlmutter AD (1972) Myelodysplasia with severe neonatal hydronephrosis: The value of urethral dilatation. J Urol 107: 146–148
Schulte-Baukloh H, Michael T, Schobert J et al. (2002) Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59: 325–328
Riccabona M, Koen M, Schindler M et al. (2004) Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171: 845–848
Marte A, Vessella A, Cautiero P et al. (2005) Efficacy of toxin-A Botulinum for treating intractable bladder hypractivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocistoplasty. Minerva Pediatr 57: 35–40
Stöhrer M, Sauerwein D (2001) Der intermittierende Katheterismus bei neurogener Blasenfunktionsstörung. Urologe B 41: 354–368
Kopp C, Greenfield SP (1993) Effects of neurogenic bladder dysfunction in utero seen in neonates with myelodysplasia. Br J Urol 71: 739–742
Gool JD van, Dik P, Jong TP de (2001) Bladder-sphincter dysfunction in myelomeningocele. Eur J Pediatr 160: 414–420
Baskin LS, Kogan BA, Benard F (1990) Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 66: 532–534
Kaefer M, Pabby A, Kelly M et al. (1999) Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele. J Urol 162: 1068–1071
Wu HY, Baskin LS, Kogan BA (1997) Neurogenic bladder dysfunction due to myelomeningocele: Neonatal versus childhood treatment. J Urol 157: 2295–2297
Edelstein RA, Bauer SB, Kelly MD et al. (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154: 1500–1504
McDonald CM, Scavone T (2000) Clean intermittent catheterization of infants with myelodysplasia, initiation of clean intermittent catheterization in infants with myelodysplasia. Dialog Ped Urol 23: 4–6
Teichman JM, Scherz HC, Kim KD et al. (1994) An alternative approach to myelodysplasia management: Aggressive observation and prompt intervention. J Urol 152: 807–811
Kasabian NG, Bauer SB, Dyro FM et al. (1992) The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146: 840–843
Kaufman AM, Ritchey ML, Roberts AC et al. (1996) Decreased bladder compliance in patients with myelomeningocele treated with radiological observation. J Urol 156: 2031–2033
Sidi AA, Dykstra DD, Gonzalez R (1986) The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study. J Urol 135: 90–93
Schlager TA, Clark M, Anderson S (2001) Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catheterization for bladder emptying. Pediatrics 108: 71
Hudson E, Murahata RI (2005) The ‚no-touch‘ method of intermittent urinary catheter insertion: Can it reduce the risk of bacteria entering the bladder? Spinal Cord 43: 611–614
McLaughlin JF, Murray M, Van Zandt K, Carr M (1996) Clean intermittent catheterization. Dev Med Child Neurol 38: 446–454
Borzyskowski M, Cox A, Edwards M, Owen A (2004) Neuropathic bladder and intermittent catheterization: Social and psychological impact on families. Dev Med Child Neurol 46: 160–167
Edwards M, Borzyskowski M, Cox A, Badcock J (2004) Neuropathic bladder and intermittent catheterization: Social and psychological impact on children and adolescents. Dev Med Child Neurol 46: 168–177
Lindehall B, Abrahamsson K, Hjalmas K et al. (2004) Complications of clean intermittent catheterization in boys and young males with neurogenic bladder dysfunction. J Urol 172: 1686–1688
Campbell JB, Moore KN, Voaklander DC, Mix LW (2004) Complications associated with clean intermittent catheterization in children with spina bifida. J Urol 171: 2420–2422
Wyndaele JJ, Maes D (1990) Clean intermittent self-catheterization: a 12-year followup. J Urol 143: 906–908
Thirumavalavan VS, Ransley PG (1992) Epididymitis in children and adolescents on clean intermittent catheterisation. Eur Urol 22: 53–56
Kaye MC, Levin HS, Montague DK, Pontes JE (1992) Squamous cell carcinoma of the bladder in a patient on intermittent self-catheterization. Cleve Clin J Med 59: 645–646
Reisman EM, Preminger GM (1989) Bladder perforation secondary to clean intermittent catheterization. J Urol 142: 1316–1317
Solomon MH, Koff SA, Diokno AC (1980) Bladder calculi complicating intermittent catheterization. J Urol 124: 140–141
Schlager TA, Dilks S, Trudell J et al. (1995) Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr 126: 490–496
Ottolini MC, Shaer CM, Rushton HG et al. (1995) Relationship of asymptomatic bacteriuria and renal scarring in children with neuropathic bladders who are practicing clean intermittent catheterization. J Pediatr 127: 368–372
Gonzalez R, Schimke CM (2002) Strategies in urological reconstruction in myelomeningocele. Curr Opin Urol 12: 485–490
Adams MC, Joseph DB (2002) Urinary tract reconstruction in children. In: Walsh PC, Retik A, Vaughan ED Jr, Wein AJ (eds) Campbell’s Urology, 8th edn. Saunders, Philadelphia, pp 2508–2563
Rawashdeh YF, Jorgensen TM, Olsen LH, Djurhuus JC (2004) The outcome of detrusor myotomy in children with neurogenic bladder dysfunction. J Urol 171: 2654–2656
MacNeily AE, Afshar K, Coleman GU, Johnson HW (2003) Autoaugmentation by detrusor myotomy: Its lack of effectiveness in the management of congenital neuropathic bladder. J Urol 170: 1643–1646
Etker S (1996) Eckstein’s Ureterocystoplasty: Notes. In: Williams DI, Etker S (eds) Contemporary issues in pediatric urology in memoriam Herbert B Eckstein. Pediatric Cerrahi Dergisi, Istanbul, pp 213–215
Bellinger MF (1993) Ureterocystoplasty: A unique method for vesical augmentation in children. J Urol 149: 811–813
Stein R, Beetz R, Thuroff JW (2004) Children and youths with neurogenic disturbances of bladder function. Bladder augmentation, substitution and the diversion of urine. Urologe A 43: 414–420
Woodhouse CR (1992) Reconstruction of the lower urinary tract for neurogenic bladder: lessons from the adolescent age group. Br J Urol 69: 589–593
Gonzalez R, Sidi AA (1985) Preoperative prediction of continence after enterocystoplasty or undiversion in children with neurogenic bladder. J Urol 134: 705–707
Herschorn S, Hewitt RJ (1998) Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 52: 672–678
Rink RC, Hollensbe D, Adams MC (1995) Complications of bladder augmentation in children and comparision of gastrointestinal segments. AUA Update series XIV: 122–128
Pope JCt, Keating MA, Casale AJ, Rink RC (1998) Augmenting the augmented bladder: Treatment of the contractile bowel segment. J Urol 160: 854–857
Bauer SB, Hendren WH, Kozakewich H et al. (1992) Perforation of the augmented bladder. J Urol 148: 699–703
Blyth B, Ewalt DH, Duckett JW, Snyder HM 3rd (1992) Lithogenic properties of enterocystoplasty. J Urol 148: 575–579
Palmer LS, Franco I, Kogan SJ et al. (1993) Urolithiasis in children following augmentation cystoplasty. J Urol 150: 726–729
Kronner KM, Casale AJ, Cain MP et al. (1998) Bladder calculi in the pediatric augmented bladder. J Urol 160: 1096–1103
Mitrofanoff P (1980) [Trans-appendicular continent cystostomy in the management of the neurogenic bladder]. Chir Pediatr 21: 297–305
Mevorach RA, Hulbert WC, Merguerian PA, Rabinowitz R (1992) Perforation and intravesical erosion of a ventriculoperitoneal shunt in a child with an augmentation cystoplasty. J Urol 147: 433–434
Couillard DR, Vapnek JM, Rentzepis MJ, Stone AR (1993) Fatal perforation of augmentation cystoplasty in an adult. Urology 42: 585–588
Matthews GJ, Churchill BA, McLorie GA, Khoury AE (1996) Ventriculoperitoneal shunt infection after augmentation cystoplasty. J Urol 155: 686–688
Yerkes EB, Rink RC, Cain MP et al. (2001) Shunt infection and malfunction after augmentation cystoplasty. J Urol 165: 2262–2264
Husmann OA, Cain MP (2001) Fecal and urinary continence after ileal cecal cystoplasty for the neurogenic bladder. J Urol 165: 922–925
Hunt GM, Poulton A (1995) Open spina bifida: A complete cohort reviewed 25 years after closure. Dev Med Child Neurol 37: 19–29
Stein R, Fisch M, Stockle M et al. (1996) Colonic conduit in children: Protection of the upper urinary tract 16 years later? J Urol 156: 1146–1150
Shapiro SR, Lebowitz R, Coldny AH (1975) Fate of 90 children with ileal conduit urinary diversion a decade later: Analysis of complication, pyelography, renal function and bacteriology. J Urol 114: 289–295
Schwarz GR, Jeffs RD (1975) Ileal conduit urinary diversion in children: Computer analysis of followup from 2 to 16 years. J Urol 114: 285
Middleton AW, Hendren WH (1976) Ileal conduit in children at the Massachusetts Genaral Hospital from 1955 to 1970. J Urol 115: 591
Duckett JW Jr (1974) Cutaneous vesicostomy in childhood. The Blocksom technique. Urol Clin North Am 1: 485–495
Borjeson MC, Lagergren J (1990) Life conditions of adolescents with myelomeningocele. Dev Med Child Neurol 32: 698–706
Peeker R, Damber JE, Hjalmas K et al. (1997) The urological fate of young adults with myelomeningocele: A three decade follow-up study. Eur Urol 32: 213–217
Light JK, Pietro T (1986) Alteration in detrusor behavior and the effect on renal function following insertion of the artificial urinary sphincter. J Urol 136: 632–635
Kassouf W, Capolicchio G, Berardinucci G, Corcos J (2001) Collagen injection for treatment of urinary incontinence in children. J Urol 165: 1666–1668
Gonzalez R, Sheldon CA (1982) Artificial sphincters in children with neurogenic bladders: long-term results. J Urol 128: 1270–1272
Grein U, Schreiter F (1990) Le sphincter artificiel chez l‚enfant. J Urol 2: 93
Kryger JV, Spencer Barthold J, Fleming P, Gonzalez R (1999) The outcome of artificial urinary sphincter placement after a mean 15-year follow-up in a paediatric population. BJU Int 83: 1026–1031
Kryger JV, Gonzalez R, Barthold JS (2000) Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol 163: 256–263
Herndon CD, Rink RC, Shaw MB et al. (2004) Experience with non-cycled artificial urinary sphincters. BJU Int 93: 1049–1052
Dik P, Van Gool JD, De Jong TP (1999) Urinary continence and erectile function after bladder neck sling suspension in male patients with spinal dysraphism. BJU Int 83: 971–975
Kropp KA, Angwafo FF (1986) Urethral lengthening and reimplantation for neurogenic incontinence in children. J Urol 135: 533–536
Nill TG, Peller PA, Kropp KA (1990) Management of urinary incontinence by bladder tube urethral lengthening and submucosal reimplantation. J Urol 144: 559–563
Kropp KA (1999) Bladder neck reconstruction in children. Urol Clin North Am 26: 661–672
Waters PR, Chehade NC, Kropp KA (1997) Urethral lengthening and reimplantation: Incidence and management of catheterization problems. J Urol 158: 1053–1056
Snodgrass W (1997) A simplified Kropp procedure for incontinence. J Urol 158: 1049–1052
Salle JL, Fraga JC de, Amarante A et al. (1994) Urethral lengthening with anterior bladder wall flap for urinary incontinence: a new approach. J Urol 152: 803–806
Salle JL, McLorie GA, Bagli DJ, Khoury AE (1997) Urethral lengthening with anterior bladder wall flap (Pippi Salle procedure): Modifications and extended indications of the technique. J Urol 158: 585–590
Mouriquand PD, Sheard R, Phillips N et al. (1995) The Kropp-onlay procedure (Pippi Salle procedure): A simplification of the technique of urethral lengthening. Preliminary results in eight patients. Br J Urol 75: 656–662
Rink RC, Adams MC, Keating MA (1994) The flip-flap technique to lengthen the urethra (Salle procedure) for treatment of neurogenic urinary incontinence. J Urol 152: 799–802
Cass AS, Luxenberg M, Johnson CF, Gleich P (1985) Incidence of urinary tract complications with myelomeningocele. Urology 25: 374–378
Klose AG, Sackett CK, Mesrobian HG (1990) Management of children with myelodysplasia: urological alternatives. J Urol 144: 1446–1449
Flood HD, Ritchey ML, Bloom DA et al. (1994) Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 152: 1574–1577
Lindehall B, Claesson I, Hjalmas K, Jodal U (1991) Effect of clean intermittent catheterisation on radiological appearance of the upper urinary tract in children with myelomeningocele. Br J Urol 67: 415–419
Hefti F (Hrsg) (1997) Kinderorthopädie in der Praxis. Springer, Berlin Heidelberg New York
Samuelsson L, Skoog M (1988) Ambulation in patients with myelomeningocele: A multivariate statistical analysis. J Pediatr Orthop 8: 569–575
Greene WB (1998) Treatment of hip and knee problems in myelomeningocele. J Bone Joint Surg Am 80: 1068–1082
Eseverri JL, Botey J, Cozzo M et al. (1999) Prevalence of allergy to latex in the pediatric population. Allergol Immunopathol (Madr) 27: 133–140
Rendeli C, Nucera E, Ausili E et al. (2005) Latex sensitisation and allergy in children with myelomeningocele. Childs Nerv Syst 22: 28–32
Palmieri A, Battistini E, Cama A et al. (1998) High prevalence of sensitization to inhalant allergens in patients with myelomeningocele allergic to latex products. Eur J Pediatr Surg 8(Suppl 1): 67–68
Shah S, Cawley M, Gleeson R et al. (1998) Latex allergy and latex sensitization in children and adolescents with meningomyelocele. J Allergy Clin Immunol 101: 741–746
Pittman T, Kiburz J, Gabriel K et al. (1995) Latex allergy in children with spina bifida. Pediatr Neurosurg 22: 96–100
Yassin MS, Sanyurah S, Lierl MB et al. (1992) Evaluation of latex allergy in patients with meningomyelocele. Ann Allergy 69: 207–211
Kurup VP, Kelly KJ, Resnick A et al. (1992) Characterization of latex antigen and demonstration of latex-specific antibodies by enzyme-linked immunosorbent assay in patients with latex hypersensitivity. Allergy Proc 13: 329–334
Nguyen DH, Burns MW, Shapiro GG et al. (1991) Intraoperative cardiovascular collapse secondary to latex allergy. J Urol 146: 571–574
Lie HR, Lagergren J, Rasmussen F et al. (1991) Bowel and bladder control of children with myelomeningocele: a Nordic study. Dev Med Child Neurol 33: 1053–1061
Kropp KA, Voeller KK (1981) Cryptorchidism in meningomyelocele. J Pediatr 99: 110–113
DGU (2001) Leitlinien der Deutschen Gesellschaft für Urologie: Diagnostik und Therapie von Libido- und Erektionsstörungen. AWMF-Leitlinien-Register Nr.043/031 Entwicklungsstufe: 1
Cass AS, Bloom BA, Luxenberg M (1986) Sexual function in adults with myelomeningocele. J Urol 136: 425–426
Woodhouse CR (2001) Prospects for fertility in patients born with genitourinary anomalies. J Urol 165: 2354–2360
Woodhouse CR (1998) Sexual function in boys born with exstrophy, myelomeningocele, and micropenis. Urology 52: 3–11
Palmer JS, Kaplan WE, Firlit CF (2000) Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol 164: 958–961
Löchner-Ernst D, Mandalka B (1997) Fertilitätsprogramm für querschnittgelähmte Männer – Übersicht und Ergebnisse. In: Stöhrer M, Madersbacher H, Palmtag H (Hrsg) Neurogene Sexualstörung. Springer, Berlin Heidelberg New York
Vylder A de, Driel MF van, Staal AL et al. (2004) Myelomeningocele and female sexuality: an issue? Eur Urol 46: 421–426
Koletzko B, Pietrzik K (2004) Gesundheitliche Bedeutung der Folsäurezufuhr. Dtsch Arztebl 101: 1670–1681
Beetz R, Bachmann H, Gatermann S et al. (2007) Urinary tract infections in infants and children – a consensus on diagnostic, therapy and prophylaxis. Urologe A 46(2): 112–123
Galloway A (1997) Prevention of urinary tract infection in patients with spinal cord injury – a microbiological review. Spinal Cord 35: 198–204
Biering-Sorensen F, Hoiby N, Nordenbo A et al. (1994) Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol 151: 105–108
Johnson HW, Anderson JD, Chambers GK et al. (1994) A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 93: 752–755
Kuhlemeier KV, Stover SL, Lloyd LK (1985) Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 134: 514–517
Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 138: 336–340
Morton SC, Shekelle PG, Adams JL et al. (2002) Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 83: 129–138
Hauschild G, Schone D, Wasser S (1968) Follow-up therapy of urinary tract infections with ammonium chloride. Kinderarztl Prax 36: 441–446
Murphy FJ, Zelman S, Mau W (1965) Ascorbic acid as a urinary acidifying agent. 2. Its adjunctive role in chronic urinary infection. J Urol 94: 300–303
Nahata MC, Shrimp L, Lampman T, McLeod DC (1977) Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm 34: 1234–1237
Wall I, Tiselius HG (1990) Long-term acidification of urine in patients treated for infected renal stones. Urol Int 45: 336–341
Fünfstück R, Straube E, Schildbach O, Tietz U (1997) Reinfektionsprophylaxe durch L-Methionin bei Patienten mit einer rezidivierenden Harnwegsinfektion. Med Klinik 92: 574–581
Sobota AE (1984) Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol 131: 1013–1016
Jepson RG, Mihaljevic L, Craig J (2004) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2: CD001321
Reid G, Hsiehl J, Potter PMed Klinik (2001) Cranberry juice consumption may reduce biofilms on uroepithelial cells: Pilot study in spinal cord injured patients. Spinal Cord 39: 26–30
Schlager TA, Anderson S, Trudell J, Hendley JO (1999) Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 135: 698–702
Lown B (Hrsg) (2004) Die verlorene Kunst des Heilens. Suhrkamp, Stuttgart
Erickson DV, Ray LD (2004) Children with chronic continence problems: The challenges for families. J Wound Ostomy Continence Nurs 31: 215–222
Sozialgesetzbuch (1998) Sozialgesetzbuch IX §§ 29 (Organisation) und 55 (Leistungen zur Teilhabe am Leben in der Gemeinschaft. Hilfen zum Erwerb praktischer Kenntnisse und Fähigkeiten). Sozialgesetzbuch
Zickler CF, Richardson V (2004) Achieving continence in children with neurogenic bowel and bladder. J Pediatr Health Care 18: 276–283
Buran CF, McDaniel AM, Brei TJ (2002) Needs assessment in a spina bifida program: A comparison of the perceptions by adolescents with spina bifida and their parents. Clin Nurse Spec 16: 256–262
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, R., Schröder, A., Beetz, R. et al. Urologischer Erkrankungen bei Patienten mit Meningomyelozele. Urologe 46, 1620–1642 (2007). https://doi.org/10.1007/s00120-007-1522-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-007-1522-3
Schlüsselwörter
- Neurogene Blase
- Meningomyelozele
- Pharmakotherapie
- CIC
- Antibiotische Infektionsrophylaxe
- Harnweginfektion
- Latexallergie
- Darmentleerungsstörung
- Harnableitung